Skip to main content
logo
OncoSil Medical Limited (ASX:OSL)
Australia flag Australia · Delayed Price · Currency is AUD
0.7150
-0.0350 (-4.67%)
Oct 7, 2026, 4:10 PM AEST

OncoSil Medical Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
262217132440
Market Cap Growth
-18.24%28.52%28.03%-43.79%-40.20%-6.18%
Enterprise Value
2019991833
Last Close Price
0.710.711.191.594.5112.21

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-6.536.536.536.536.53
PS Ratio
5.164.3111.128.5116.1637.28
PB Ratio
5.254.395.502.812.403.55
P/TBV Ratio
5.254.395.502.812.403.55

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
3.893.765.655.4612.3931.40

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.000.000.020.020.020.03
Net Debt / Equity Ratio
-1.29-1.29-1.62-0.93-0.93-0.98
Net Debt / EBITDA Ratio
0.590.590.330.370.821.04
Net Debt / FCF Ratio
0.620.620.420.400.811.09
Asset Turnover
0.580.580.220.170.120.08
Quick Ratio
1.681.681.573.066.816.89
Current Ratio
1.771.771.673.267.167.21
Return on Equity (ROE)
-268.16%-268.16%-385.20%-163.01%-107.80%-93.85%
Return on Assets (ROA)
-78.85%-78.85%-136.02%-82.34%-57.73%-48.58%
Return on Capital Employed (ROCE)
-220.10%-220.10%-482.70%-251.00%-114.40%-93.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-41.38%-49.52%-88.48%-89.39%-47.84%-27.05%
FCF Yield
-39.91%-47.76%-70.77%-82.69%-47.97%-25.52%
Buyback Yield / Dilution
-107.26%-107.26%-97.77%-95.67%-39.32%0.89%